Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug
- 1 February 2004
- journal article
- Published by Elsevier in Experimental Eye Research
- Vol. 78 (4) , 767-776
- https://doi.org/10.1016/j.exer.2003.12.007
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Aqueous Humor Dynamics and Trabecular Meshwork and Anterior Ciliary Muscle Morphologic Changes with Age in Rhesus MonkeysInvestigative Opthalmology & Visual Science, 2003
- Some Thoughts on the Pressure Dependence of Uveoscleral FlowJournal of Glaucoma, 2003
- Pressure Dependence of Uveoscleral OutflowJournal of Glaucoma, 2002
- Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamicsAmerican Journal of Ophthalmology, 2001
- Phase III latanoprost studies in Scandinavia, the United Kingdom and the United StatesSurvey of Ophthalmology, 1997
- Comparison of Latanoprost and Timolol in Patients with Ocular Hypertension and GlaucomaOphthalmology, 1996
- Outflow Facility and Its Response to Pilocarpine Decline in Aging Rhesus MonkeysArchives of Ophthalmology (1950), 1991
- The effect of prostaglandin F2α on trabecular outflow facility in cynomolgus monkeysExperimental Eye Research, 1990
- Characterization of the prostanoid receptor profile of enprostil and isomers in smooth muscle and platelets in vitroBritish Journal of Pharmacology, 1989
- Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F2αCurrent Eye Research, 1981